Results 1 to 10 of about 84,841 (279)

Pulmonary Large Cell Neuroendocrine Carcinoma

Pathology and Oncology Research, 2022
Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a rare subtype of malignant pulmonary tumor. The incidence rate of LCNEC was reported to be 0.3%–3% in lung cancers.
Lan Yang, Lan Yang, Lan Yang, Lan Yang, Ying Fan, Ying Fan, Ying Fan, Ying Fan, Hongyang Lu, Hongyang Lu, Hongyang Lu, Hongyang Lu   +11 more
doaj   +3 more sources

Pulmonary large cell carcinoma with neuroendocrine morphology shows genetic similarity to large cell neuroendocrine carcinoma [PDF]

Diagnostic Pathology, 2022
Background Large cell neuroendocrine carcinoma (LCNEC) is a high-grade malignant pulmonary neuroendocrine tumour. The distinction of pulmonary large cell carcinoma (LCC) and LCNEC is based on the presence of neuroendocrine morphology and the expression ...
Zuoyu Liang, Weiya Wang, Qianrong Hu, Ping Zhou, Ying Zhang, Yuan Tang, Qian Wu, Yiyun Fu, Xue Li, Yang Shao, Lili Jiang   +10 more
doaj   +3 more sources

A case report of primary large cell neuroendocrine carcinoma of the urinary bladder [PDF]

Urology Case Reports
Neuroendocrine carcinoma (NEC) is a highly malignant tumor that originates from neuroendocrine cells, most commonly found in the gastrointestinal tract and lungs.
Yuan Liu, Qi Wang
doaj   +2 more sources

Successful treatment of large-cell neuroendocrine carcinoma of the prostate with pembrolizumab: a case report [PDF]

Journal of Medical Case Reports
Background Large-cell neuroendocrine carcinoma of the prostate is an extremely rare disease and classified into two subtypes: de novo and treatment-induced large-cell neuroendocrine carcinoma that arises from adenocarcinoma via lineage plasticity in ...
Erika Yamashita, Shingo Ashida, Rie Yoshimura, Ryohei Iga, Yoshitaka Kurano, Shinkuro Yamamoto, Tsutomu Shimamoto, Hideo Fukuhara, Satoshi Fukata, Atsushi Kurabayashi, Takashi Karashima, Keiji Inoue   +11 more
doaj   +2 more sources

Management of Large Cell Neuroendocrine Carcinoma [PDF]

Frontiers in Oncology, 2021
BackgroundLarge cell neuroendocrine carcinoma (LCNEC) is a rare, aggressive cancer with a dismal prognosis. The majority of cases occur in the lung and the gastrointestinal tract; however, it can occur throughout the body.
Virginia Corbett, Susanne Arnold, Lowell Anthony, Aman Chauhan   +3 more
doaj   +3 more sources

Hepatic metastasis of pulmonary large cell neuroendocrine carcinoma: A case report and literature review [PDF]

Journal of International Medical Research
Large cell neuroendocrine carcinoma of the lung is a rare and aggressive malignancy with a high propensity for metastasis. This carcinoma demonstrates a significantly higher propensity for hepatic metastasis compared with other non-small cell lung cancer
Jiake Wu, Yang Cai, Bei Lu, Yanan Xu, Jianyong Zhuo, Junjie Yin   +5 more
doaj   +2 more sources

A collision tumor composed of colon adenocarcinoma and large cell neuroendocrine carcinoma with gingival metastasis: a case report [PDF]

Frontiers in Oncology
Collision tumors represent a relatively uncommon form of tumor manifestation, characterized by the independent coexistence of multiple distinct types of tumors.
Zhiqiang Zhang, Junfeng Zhang, Peng Chen, Xuexia Kou, Yunsheng Lan, Yingdong Jia   +5 more
doaj   +2 more sources

Pulmonary Combined Large Cell Neuroendocrine Carcinoma

Pathology and Oncology Research, 2022
Pulmonary combined large-cell neuroendocrine carcinoma (CLCNEC) is a rare neuroendocrine tumor pertained to lung large cell neuroendocrine carcinoma (LCNEC) with aggressive behavior and poor prognosis generally.
Meihui Li, Meihui Li, Meihui Li, Meihui Li, Lan Yang, Lan Yang, Lan Yang, Hongyang Lu, Hongyang Lu, Hongyang Lu   +9 more
doaj   +3 more sources

Rectal large cell neuroendocrine carcinoma. [PDF]

Oxf Med Case Reports
Abstract Rectal large cell neuroendocrine carcinoma (LCNEC) is an exceedingly rare and aggressive neoplasm with a poor prognosis and median survival of 4–16 months. Diagnosis is challenging due to the clinical overlap with classical colorectal adenocarcinoma, and accurate diagnosis is reliant on histological examination via ...
Drakos PA, Prountzopoulou AA, Totskas E, Stamou K.   +3 more
europepmc   +2 more sources

Clinical characteristics and treatment management of combined large cell neuroendocrine carcinoma, a subtype of large cell neuroendocrine carcinoma [PDF]

Frontiers in Oncology
Combined large cell neuroendocrine carcinoma (CLCNEC) is a rare neuroendocrine carcinoma, accounting for approximately 10% of large cell neuroendocrine carcinoma (LCNEC).
Kai Kang, Binfeng Li, Sheng Wang, Jianjian Wang, Xinjun Liang   +4 more
doaj   +2 more sources